FDA sets review date for SpinalMotion's artificial disc

05/8/2013 | MassDevice.com (Boston)

An FDA panel will meet on July 24 to evaluate SpinalMotion's premarket approval application for the Kineflex/C system. The metal-on-metal total disc replacement device, which is already available in Europe, is intended for one-level repair of the intervertebral disc in patients who have undergone single-level discectomy for lumbar degenerative disc disease.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD